Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

7.70
Delayed Data
As of Dec 05
 +0.07 / +0.92%
Today’s Change
4.21
Today|||52-Week Range
8.45
+6.94%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$250.8M

Company Description

Veracyte, Inc. is a molecular diagnostics company which uses novel genomics to resolve the critical healthcare problem of diagnostic ambiguity. The company discovers, develops and commercializes molecular diagnostic solutions that enable physicians to make more informed treatment decisions early. Veracyte was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Contact Information

Veracyte, Inc.
6000 Shoreline Court
South San Francisco California 94080
P:(650) 243-6300
Investor Relations:

Employees

Shareholders

Individual stakeholders50.13%
Other institutional32.15%
Mutual fund holders17.22%

Top Executives

Bonnie H. AndersonPresident, Chief Executive Officer & Director
Christopher M. HallChief Operating Officer
Shelly D. GuyerChief Financial Officer
Giulia C. KennedyChief Scientific Officer, SVP-Research & Product
Neil M. BarthChief Medical Officer